Vanguard Group’s IGC Pharma IGC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $197K | Hold |
645,166
| – | – | ﹤0.01% | 4090 |
|
|
2025
Q1 | $184K | Hold |
645,166
| – | – | ﹤0.01% | 4085 |
|
|
2024
Q4 | $217K | Hold |
645,166
| – | – | ﹤0.01% | 4093 |
|
|
2024
Q3 | $275K | Hold |
645,166
| – | – | ﹤0.01% | 4087 |
|
|
2024
Q2 | $280K | Hold |
645,166
| – | – | ﹤0.01% | 4112 |
|
|
2024
Q1 | $258K | Hold |
645,166
| – | – | ﹤0.01% | 4138 |
|
|
2023
Q4 | $181K | Hold |
645,166
| – | – | ﹤0.01% | 4236 |
|
|
2023
Q3 | $232K | Sell |
645,166
-1,377
| -0.2% | -$495 | ﹤0.01% | 4227 |
|
|
2023
Q2 | $201K | Hold |
646,543
| – | – | ﹤0.01% | 4314 |
|
|
2023
Q1 | $220K | Hold |
646,543
| – | – | ﹤0.01% | 4305 |
|
|
2022
Q4 | $206K | Buy |
646,543
+744
| +0.1% | +$237 | ﹤0.01% | 4308 |
|
|
2022
Q3 | $278K | Hold |
645,799
| – | – | ﹤0.01% | 4359 |
|
|
2022
Q2 | $343K | Hold |
645,799
| – | – | ﹤0.01% | 4373 |
|
|
2022
Q1 | $612K | Sell |
645,799
-8,929
| -1% | -$8.46K | ﹤0.01% | 4348 |
|
|
2021
Q4 | $640K | Buy |
654,728
+456
| +0.1% | +$446 | ﹤0.01% | 4377 |
|
|
2021
Q3 | $968K | Hold |
654,272
| – | – | ﹤0.01% | 4253 |
|
|
2021
Q2 | $1.07M | Sell |
654,272
-60,100
| -8% | -$98.7K | ﹤0.01% | 4137 |
|
|
2021
Q1 | $1.28M | Hold |
714,372
| – | – | ﹤0.01% | 3957 |
|
|
2020
Q4 | $1.11M | Buy |
714,372
+243,941
| +52% | +$380K | ﹤0.01% | 3800 |
|
|
2020
Q3 | $489K | Buy |
470,431
+16,321
| +4% | +$17K | ﹤0.01% | 3823 |
|
|
2020
Q2 | $272K | Hold |
454,110
| – | – | ﹤0.01% | 3885 |
|
|
2020
Q1 | $223K | Hold |
454,110
| – | – | ﹤0.01% | 3845 |
|
|
2019
Q4 | $286K | Hold |
454,110
| – | – | ﹤0.01% | 3887 |
|
|
2019
Q3 | $441K | Hold |
454,110
| – | – | ﹤0.01% | 3842 |
|
|
2019
Q2 | $745K | Buy |
+454,110
| New | +$745K | ﹤0.01% | 3751 |
|